A large-scale clinical trial finds lanthanum carbonate does not reduce the risk of cardiovascular disease developing in patients with chronic kidney disease.The drug is routinely
Category: Uncategorized
BEST-Fluids study – recruitment complete
We are delighted to announce that recruitment for BEST-Fluids is now complete, with 808 participants enrolled. Congratulations to all the study teams for your hard
MRFF funding success
The IMPEDE-PKD and M-FIT trials have been successful in receiving funding via the Medical Research Future Fund (MRFF) rare cancers, rare diseases and unmet needs
Kidney medication ineffective
A major clinical trial run by the AKTN finds the drug allopurinol does not prevent worsening of kidney disease. University of Queensland researchers at the
Best-Fluids Trial Protocol Published
Is Plasmalyte or Saline best for preventing DGF in kidney transplantation? BEST-Fluids is a pragmatic registry trial that will answer this. Protocol has now been
A time to celebrate
Congratulations to Professor David Johnson and Dr Andrea Viecelli who have been awarded Investigator Grants from the 2020 round.They will begin their research in 2021.